Literature DB >> 23418213

Primary progressive multiple sclerosis: progress and challenges.

Claire M Rice1, David Cottrell, Alastair Wilkins, Neil J Scolding.   

Abstract

Primary progressive multiple sclerosis (MS) has long been recognised as presenting great difficulties to our management of what is increasingly a treatable neurological disease. Here we review some basic and clinical aspects of primary progressive MS, and describe how the disorder in fact offers powerful insights and opportunities for better understanding multiple sclerosis, and from a practical perspective an invaluable clinical substrate for studying and treating progressive disability in MS. Difficult hurdles remain, however, and these too are reviewed.

Entities:  

Keywords:  Multiple Sclerosis

Mesh:

Substances:

Year:  2013        PMID: 23418213     DOI: 10.1136/jnnp-2012-304140

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  Cortical excitability changes over time in progressive multiple sclerosis.

Authors:  Samar S Ayache; Alain Créange; Wassim H Farhat; Hela G Zouari; Catherine Lesage; Ulrich Palm; Mohammed Abdellaoui; Jean-Pascal Lefaucheur
Journal:  Funct Neurol       Date:  2015 Oct-Dec

2.  Frequent misdiagnosis of adult polyglucosan body disease.

Authors:  Mark A Hellmann; Or Kakhlon; Ezekiel H Landau; Menachem Sadeh; Nir Giladi; Ilana Schlesinger; Daphne Kidron; Oded Abramsky; Avinoam Reches; Zohar Argov; Jose M Rabey; Joab Chapman; Hanna Rosenmann; Aya Gal; J Moshe Gomori; Vardiella Meiner; Alexander Lossos
Journal:  J Neurol       Date:  2015-07-21       Impact factor: 4.849

Review 3.  The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury.

Authors:  Jan M Schwab; Yi Zhang; Marcel A Kopp; Benedikt Brommer; Phillip G Popovich
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

4.  Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.

Authors:  Jordana Hughes; Vilija Jokubaitis; Alessandra Lugaresi; Raymond Hupperts; Guillermo Izquierdo; Alexandre Prat; Marc Girard; Pierre Duquette; Francois Grand'Maison; Pierre Grammond; Patrizia Sola; Diana Ferraro; Cristina Ramo-Tello; Maria Trojano; Mark Slee; Vahid Shaygannejad; Cavit Boz; Jeanette Lechner-Scott; Vincent Van Pesch; Eugenio Pucci; Claudio Solaro; Freek Verheul; Murat Terzi; Franco Granella; Daniele Spitaleri; Raed Alroughani; Jae-Kwan Jun; Adam Fambiatos; Anneke Van der Walt; Helmut Butzkueven; Tomas Kalincik
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

Review 5.  The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies.

Authors:  Rokhsareh Meamar; Shahrzad Nematollahi; Leila Dehghani; Omid Mirmosayyeb; Vahid Shayegannejad; Keivan Basiri; Amir Pouya Tanhaei
Journal:  Adv Biomed Res       Date:  2016-03-16

6.  Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.

Authors:  Panagiotis Douvaras; Jing Wang; Matthew Zimmer; Stephanie Hanchuk; Melanie A O'Bara; Saud Sadiq; Fraser J Sim; James Goldman; Valentina Fossati
Journal:  Stem Cell Reports       Date:  2014-07-24       Impact factor: 7.765

Review 7.  Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS).

Authors:  Amnon A Berger; Emily R Sottosanti; Ariel Winnick; Jonathan Izygon; Kevin Berardino; Elyse M Cornett; Alan D Kaye; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Neurol Int       Date:  2021-05-19

Review 8.  Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.

Authors:  Juan Xiao; Rongbing Yang; Sangita Biswas; Xin Qin; Min Zhang; Wenbin Deng
Journal:  Int J Mol Sci       Date:  2015-04-24       Impact factor: 5.923

Review 9.  Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?

Authors:  Ahmed Abdelhak; Andreas Junker; Johannes Brettschneider; Jan Kassubek; Albert C Ludolph; Markus Otto; Hayrettin Tumani
Journal:  Int J Mol Sci       Date:  2015-07-31       Impact factor: 5.923

10.  Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.

Authors:  Shannon Kolind; Arshia Seddigh; Anna Combes; Bretta Russell-Schulz; Roger Tam; Vignan Yogendrakumar; Sean Deoni; Naomi A Sibtain; Anthony Traboulsee; Steven C R Williams; Gareth J Barker; Peter A Brex
Journal:  Neuroimage Clin       Date:  2015-10-03       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.